Drug-eluting stent

coronary stent 2
Health
National

License Raj Makes A Comeback

National Pharmaceutical Pricing Authority’s move to cap pricing of coronary stents would adversely affect well-to-do patients and medical tourism industry in India After the Delhi High court passed the order to slash the price of stents, National Pharmaceutical Pricing Authority (NPPA), a government regulatory agency issued a order on 13th Feb, 2017. This order came as […]

Read More